IMPAQ Strategy executive lead Steve Coy has been elected to serve as a member of the Board of Directors (BOD) of the Asthma and Allergy Foundation of America (AAFA). As a member of the BOD, Steve will provide insight to support AAFA’s mission of improving the quality of life for people with asthma and allergic diseases through education, advocacy and research.
Steve brings over 30 years of experience in providing vision, leadership, and business acumen to a wide variety of organizations in the healthcare, education, research, information services, and technology industries. He has a proven track record of success in creating new business lines and expanding current product and service reach in start-ups, nonprofits, and established companies.
“The opportunity to leverage my experience in patient registries and digital products will support AAFA as they continue to build patient engagement, research and collaboration products”, said Steve. “Building a platform for research will allow AAFA to better understand diseases, educate patients and caregivers, and support scientific inquiry in order to identify the most appropriate treatments for each patient.”
Steve’s support of AAFA builds upon IMPAQ Strategy’s support for professional medical societies, patient advocacy foundations, and other nonprofits that are interested in improving the health and well being of the nation. IMPAQ Strategy currently provides strategic direction in the fields of pathology, pediatrics, oncology, psychiatry, infectious disease, and urogynecology.
“Steve has tremendous expertise in the development of innovative strategies for mission-driven organizations,” stated Dr. Cary Sennett, CEO of AAFA. “AAFA is fortunate to have him as a member of the BOD, and we believe his insight will help guide our organization toward new and exciting initiatives necessary to improve the health of people with asthma, food allergies and allergic diseases using data registries and digital services.”